Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.

its use is restricted within the allergic asthma subtype. The treatment of an already established exacerbation is more straight forward than its prevention. It comprises of oxygenation ...

A recent study published in The Journal of Allergy and Clinical Immunology: In Practice found that gestational diabetes ...

The FDA approval of Airsupra permits use for as-needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations in people with asthma aged 18 years and older.

Yes, people have died from asthma, including children and adults. Learn about socioeconomic variables and comorbid factors in ...

According to a recent study, financial constraint was a major contributor to nonadherence to medications in adults with ...

The following is a summary of “Clinical remission attainment, definitions, and correlates among patients with severe asthma ...

"For me, preventing exacerbations, and particularly those that lead to hospitalisations, is a treatment priority for the people I see with severe asthma," he added. "Not only are exacerbations ...

BOSTON — Patients with obesity and asthma may see reductions in exacerbations with biologic treatment, according to a presentation at the CHEST Annual Meeting. After an historic rate hike cycle ...